US Congressmen investigate 'staggering price increases' for generic drugs

Letters have been sent to 14 drug manufacturers, including several major Indian firms, requesting information about the escalating prices they have been charging for generic drugs in the USA by Representative Elijah Cummings, ranking member of the House Committee on Oversight and Government Reform, and Senator Bernard Sanders, chairman of the Subcommittee on Primary Health and Aging, Senate Committee on Health, Education, Labor and Pensions,

Rep Cummings and Sen Sanders are investigating price increases for drugs used to treat everything from common medical conditions to life-threatening illnesses and to identify measures to help reduce costs for patients, health care providers, and hospitals across the country.

The drugmakers receiving the letters are: Actavis; Apotex Corp; Dr Reddy’s Laboratories; Endo International; Global Pharmaceuticals; Heritage Pharmaceuticals; Lannett Company; Marathon Pharmaceuticals; Mylan; Par Pharmaceutical Companies; Sun Pharmaceutical Industries; Teva Pharmaceutical Industries; West-Ward Pharmaceutical; and Zydus Pharmaceuticals.